Ashley Dreier Sells 10,000 Shares of Healthequity Inc (HQY) Stock
Healthequity Inc (NASDAQ:HQY) VP Ashley Dreier sold 10,000 shares of Healthequity stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $45.50, for a total transaction of $455,000.00. Following the completion of the transaction, the vice president now directly owns 15,652 shares of the company’s stock, valued at $712,166. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Healthequity Inc (NASDAQ HQY) traded up 1.57% during mid-day trading on Friday, hitting $44.64. 698,160 shares of the stock were exchanged. The firm has a market cap of $2.68 billion, a price-to-earnings ratio of 83.91 and a beta of 1.75. The stock has a 50-day moving average price of $45.13 and a 200 day moving average price of $45.84. Healthequity Inc has a 52-week low of $30.34 and a 52-week high of $54.95.
Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.14 by $0.13. The firm had revenue of $56.90 million during the quarter, compared to analyst estimates of $55.66 million. Healthequity had a net margin of 25.31% and a return on equity of 20.36%. Healthequity’s revenue was up 28.7% on a year-over-year basis. During the same period last year, the firm posted $0.16 EPS. On average, equities research analysts expect that Healthequity Inc will post $0.70 earnings per share for the current year.
HQY has been the subject of several recent analyst reports. BidaskClub cut shares of Healthequity from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a report on Wednesday, July 12th. TheStreet raised shares of Healthequity from a “c” rating to a “b” rating in a report on Monday, July 31st. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 target price on shares of Healthequity in a report on Tuesday. Finally, Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and issued a $61.00 target price (up from $57.00) on shares of Healthequity in a report on Monday, June 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $52.13.
Several institutional investors have recently made changes to their positions in the stock. BlackRock Inc. raised its position in shares of Healthequity by 4.3% in the 2nd quarter. BlackRock Inc. now owns 5,831,014 shares of the company’s stock valued at $290,559,000 after purchasing an additional 241,061 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Healthequity by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock valued at $211,145,000 after purchasing an additional 122,061 shares during the last quarter. Wasatch Advisors Inc. raised its position in shares of Healthequity by 2.2% in the 2nd quarter. Wasatch Advisors Inc. now owns 2,442,180 shares of the company’s stock valued at $121,694,000 after purchasing an additional 52,885 shares during the last quarter. FMR LLC raised its position in shares of Healthequity by 45.6% in the 2nd quarter. FMR LLC now owns 2,235,150 shares of the company’s stock valued at $111,378,000 after purchasing an additional 699,728 shares during the last quarter. Finally, Janus Henderson Group PLC raised its position in shares of Healthequity by 627.9% in the 2nd quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock valued at $105,292,000 after purchasing an additional 1,822,732 shares during the last quarter. 91.86% of the stock is owned by hedge funds and other institutional investors.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.